Head Of Corporate Development At Intarcia Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Head of corporate development at intarcia therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Head Of Corporate Development At Intarcia Therapeutics Today - Breaking & Trending Today

Wren Therapeutics Announces Financing of 12.4 Million (c. $17.0 Million)

Posted on
7440
Wren Therapeutics Ltd., (“Wren”), a biopharmaceutical company pioneering a unique network kinetics approach to drug discovery for protein misfolding diseases, today announced the closing of a £12.4 million (c. $17.0 million) financing.
This financing brings the total capital raised to date to approximately £33 million (c. $45 million). The financing was led by existing shareholder The Baupost Group, with participation from existing investors including LifeForce Capital and new investors including Schooner Capital and Industry Ventures.
Dr. Samuel Cohen, Chief Executive Officer of Wren, commented: “This support from both our existing as well as our new shareholders will accelerate the advancement of our two lead small molecule programs towards the clinic for the potential treatment of Alzheimer’s disease and various synucleinopathies including Parkinson’s disease.” ....

United States , Rowen Hughes , Samuel Cohen , Emer Reynolds , Lund University Sweden , Milken Institute , National Cancer Institute , Dartmouth College , Board Of Bausch Health , Baupost Group , Board Of Directors At Radius Health , Fidelity Investments Company , Celularity Inc , University Of Cambridge United Kingdom , Georgetown University , Radius Health , Clinical Development , Bausch Health , University Of Texas Md Anderson Cancer Center , National Institutes Of Health , Drug Administration , Bipartisan Policy Center , Samaritan Health Initiatives Inc , Eisai Co Ltd , Head Of Corporate Development At Intarcia Therapeutics , Wren Therapeutics Ltd ,

Wren Therapeutics Announces Financing of £12.4 Million (c. $17.0 Million)

Press release content from Business Wire. The AP news staff was not involved in its creation.
Wren Therapeutics Announces Financing of £12.4 Million (c. $17.0 Million)
January 25, 2021 GMT
CAMBRIDGE, United Kingdom (BUSINESS WIRE) Jan 25, 2021
Wren Therapeutics Ltd., (“Wren”), a biopharmaceutical company pioneering a unique network kinetics approach to drug discovery for protein misfolding diseases, today announced the closing of a £12.4 million (c. $17.0 million) financing.
This financing brings the total capital raised to date to approximately £33 million (c. $45 million). The financing was led by existing shareholder The Baupost Group, with participation from existing investors including LifeForce Capital and new investors including Schooner Capital and Industry Ventures. ....

United Kingdom , United States , Rowen Hughes , Samuel Cohen , Emer Reynolds , Lund University Sweden , Milken Institute , National Cancer Institute , Dartmouth College , Board Of Bausch Health , Baupost Group , Board Of Directors At Radius Health , Fidelity Investments Company , Celularity Inc , University Of Cambridge United Kingdom , Georgetown University , Radius Health , Clinical Development , Bausch Health , University Of Texas Md Anderson Cancer Center , National Institutes Of Health , Drug Administration , Bipartisan Policy Center , Samaritan Health Initiatives Inc , Eisai Co Ltd , Head Of Corporate Development At Intarcia Therapeutics ,

Cullinan Oncology Seeks U.S. IPO For Pipeline Development (Pending:CGEM)

Cullinan Oncology Seeks U.S. IPO For Pipeline Development (Pending:CGEM)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Rowen Hughes , Morgan Stanley , Oncology Impact Fund , Company Technology , Dizal Pharmaceuticals , Spectrum Pharmaceuticals , Head Of Corporate Development At Intarcia Therapeutics , View Research , Taiho Pharmaceuticals , Hc Wainwright Co , Massachusetts Based Cullinan , Chief Business Officer , Corporate Development , Intarcia Therapeutics , Impact Fund , Foresite Capital , Grand View Research , Compound Annual Growth Rate , Diamond Therapeutics , ஒன்றுபட்டது கிஂக்டம் , ஓவந் ஹக்ஸ் , மோர்கன் ஸ்டான்லி , புற்றுநோயியல் தாக்கம் நிதி , நிறுவனம் தொழில்நுட்பம் , டிஜல் மருந்துகள் ,